Now live: Pro — the full 13F research suite for serious investorsSee pricing →
Discovery Value Fund

Q3 2023 · 13F-HR

Discovery Value Fundholdings as filed

Filed 2023-11-09 · accession 0001750451-23-000006

$182.4M
Reported value
6
Positions
2023-09-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
25809K105DASHDOORDASH INC$131.0M71.8%1,648,516CommonSOLE
46090E103QQQINVESCO QQQ TR$25.6M14.0%71,488CommonSOLE
45826J105NTLAINTELLIA THERAPEUTICS INC$17.8M9.73%561,561CommonSOLE
67066G104NVDANVIDIA CORPORATION$4.0M2.21%9,249CommonSOLE
037833100AAPLAPPLE INC$2.7M1.50%15,998CommonSOLE
87918A105TDOCTELADOC HEALTH INC$1.3M0.72%70,427CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.